Intended for healthcare professionals

Letters Sentinel node biopsy for melanoma

Sentinel node biopsy in melanoma is not a good prognostic marker for individual patients

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f651 (Published 06 February 2013) Cite this as: BMJ 2013;346:f651
  1. Jonathan L Rees, professor of dermatology1
  1. 1University of Edinburgh, Edinburgh EH3 9HA, UK
  1. jonathan.rees{at}ed.ac.uk

Torjesen deserves credit for her article on sentinel node biopsy (SNB) in melanoma,1 but it is sad that medicine needs a journalist to put its own house in order (excepting people like John Meirion Thomas). So much for evidence based medicine.

Other commentators have pointed out that the evidence that …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription